Method of treating, preventing, inhibiting or reducing damage to cardiac tissue

Details for Australian Patent Application No. 2005277094 (hide)

International Classifications

Event Publications

1 March 2007 PCT application entered the National Phase

PCT publication WO2006/023910 Priority application(s): WO2006/023910

3 May 2007 Change of Name(s) of Applicant(s), Section 104

Regenerx Biopharmaceuticals, Inc.; The University of Texas Southwestern Medical Center at Dalls System The name of the applicant has been changed to Regenerx Biopharmaceuticals, Inc.; The Board of Regents of The University of Texas System

14 June 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 28 Mar 2007 and 03 May 2007

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.